0000899243-23-007174.txt : 20230306
0000899243-23-007174.hdr.sgml : 20230306
20230306160512
ACCESSION NUMBER: 0000899243-23-007174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230302
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alloway Paul
CENTRAL INDEX KEY: 0001916155
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 23708907
MAIL ADDRESS:
STREET 1: C/O HOMOLOGY MEDICINES, INC.
STREET 2: 45 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Homology Medicines, Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-301-7277
MAIL ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-02
0
0001661998
Homology Medicines, Inc.
FIXX
0001916155
Alloway Paul
C/O HOMOLOGY MEDICINES, INC.
ONE PATRIOTS PARK
BEDFORD
MA
01730
0
1
0
0
See Remarks
Common Stock
2023-03-02
4
S
0
10965
1.4467
D
16706
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2022.
This transaction reports the sale of 10,965 shares which were acquired on February 28, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.
The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.37 to $1.52. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.
Chief Legal Officer and Secretary
/s/ Paul Alloway
2023-03-06